Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 34,838 | 26,852 | 25,039 | 23,475 | 22,758 |
| Cost of Goods | 7,686 | 5,944 | 4,597 | 4,500 | 3,697 |
| Gross Profit | 27,152 | 20,908 | 20,442 | 18,975 | 19,061 |
| Operating Expenses | 31,809 | 46,368 | 36,210 | 31,289 | 28,568 |
| Operating Income | -3,971 | -24,516 | -15,171 | -11,814 | -8,810 |
| Interest Expense | 4 | 3 | 0 | 0 | 0 |
| Other Income | 370 | 30 | 16 | 23 | 24 |
| Pre-tax Income | -3,605 | -24,489 | -15,155 | -11,791 | -8,786 |
| Income Tax | -1,957 | 134 | -8,725 | N/A | 5 |
| Net Income Continuous | -1,648 | -24,623 | -6,430 | -11,791 | -8,791 |
| Net Income | $-1,648 | $-24,623 | $-6,430 | $-11,791 | $-8,791 |
| EPS Basic Total Ops | -0.06 | -0.97 | -0.25 | -0.47 | -0.35 |
| EPS Basic Continuous Ops | -0.06 | -0.97 | -0.26 | -0.47 | -0.35 |
| EPS Diluted Total Ops | -0.06 | -0.97 | -0.25 | -0.47 | -0.35 |
| EPS Diluted Continuous Ops | -0.06 | -0.97 | -0.26 | -0.47 | -0.35 |
| EBITDA(a) | $-1,343 | $-22,365 | $-13,720 | $-10,725 | $-8,176 |